Liam is a synthetic organic chemist interested in the design, synthesis, and application of novel fluorescent probes for biological studies. 

Xylo is developing new therapies for patients with psychiatric and neurological disorders. The approach is to develop compounds that enhance neuroplasticity with the aim of addressing the underlying dysfunctions in these disorders instead of only managing symptoms.